Sign up
Pharma Capital

LeanLife hits new milestone, ships first Omega-3 product samples

The Vancouver-based company developed a patented process to isolate Omega-3 fatty acids from flax seeds that can be used as food additives or nutraceuticals
omega-3
LeanLife shipped samples of its Omega-3 products to a potential consumer base in Europe

LeanLife Health Inc (CSE:LLP) has shipped its first Omega-3 product samples to potential customers in Europe, the company announced Thursday.

Shares jumped around 33% on Thursday morning to reach C$0.06 in Canada.

The Vancouver-based company develops proprietary plant-based food products that can be used as food additives or nutraceuticals. It has a patented process to isolate Omega-3 fatty acids from flax seeds.

LeanLife’s proprietary Omega-3 product was shipped to Europe, where it will be distributed to a consumer base of some of the continent’s largest producers of bread, pasta, cheese, yogurt and butter.

READ: LeanLife testing exceeds expectations, gears up for commercialization of Omega-3 fatty acids

Recently, a trial application using the Omega-3 product as a substitute for vegetable oil showed negligible difference in taste and quality, LeanLife said in a statement.

The testing resulted in the production of samples which will now be evaluated by a third-party accredited lab.

According to the extract manufacturer, the company is ready to begin large-scale production and fulfill multiple orders following the validation of samples by buyers.

CEO Stan Lis said that LeanLife is “very excited” to be back in production. “Now that LeanLife is capable of producing in large volumes, the shipping of samples to potential customers that have been waiting for our product brings the company to the verge of revenue generation in this multi-billion dollar market,” he said in a statement.

“Our salesforce in Europe has been eagerly awaiting the opportunity to revisit potential customers. As the awareness of the importance of healthy eating continues to expand, LeanLife intends to meet the growing consumer demand for plant-based essential food ingredients.”

The global Omega-3 market reached US$33 billion in 2016 and is expected to reach nearly US$57 billion by 2025, according to data provided by LeanLife.

--Updates with share price--

Contact Angela at [email protected]

Follow her on Twitter @AHarmantas

1553005391_Angela2.jpg
Why Invest In LeanLife Health? Read More Here

Register here to be notified of future LLP Company articles
View full LLP profile View Profile
Newswire

LeanLife issues stock options

View All

Related Articles

© biotech Capital 2019

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.